CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• F. Cash Flow Y/Y Annual
Qiagen N v   (NYSE: QGEN)
Other Ticker:  
 
 

QGEN's Free Cash Flow Growth by Quarter and Year

Qiagen N V 's Free Cash Flow results by quarter and year

 



QGEN Free Cash Flow (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December 673.55 459.46 715.26 639.00
3rd Quarter September 0.00 0.00 0.00 0.00
2nd Quarter June 0.00 0.00 0.00 0.00
1st Quarter March 0.00 0.00 0.00 0.00
FY   673.55 459.46 715.26 639.00

QGENs Annual Free Cash Flow
Qiagen N V 's Free Cash Flow in the fiscal year 2024 $ 502.31 millions
Qiagen N V 's Free Cash Flow in the fiscal year 2023 $ 296.65 millions
Qiagen N V 's Free Cash Flow in the fiscal year 2022 $ 0.00 millions
Qiagen N V 's Free Cash Flow in the fiscal year 2021 $ 432.47 millions
Qiagen N V 's Free Cash Flow in the fiscal year 2019 $ 55.96 millions




QGEN Free Cash Flow forth quarter 2024 Y/Y Growth Comment
Qiagen N V showed record Free Cash Flow increase in the forth quarter 2024 with 46.6% from the forth quarter 2024 2023, to $ 673.55 millions.

Looking into forth quarter 2024 results within Biotechnology & Pharmaceuticals industry 8 other companies have achieved higher Free Cash Flow growth. While Qiagen N V ' s Free Cash Flow jump of 46.6% ranks overall at the positon no. 553 in the forth quarter 2024.


QGEN Free Cash Flow ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December 46.6 % -35.76 % 11.93 % 93.14 %
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   46.6 % -35.76 % 11.93 % 93.14 %

Financial Statements
Qiagen N V 's forth quarter 2024 Free Cash Flow $ 673.55 millions QGEN's Income Statement
Qiagen N V 's forth quarter 2023 Free Cash Flow $ 459.46 millions Quarterly QGEN's Income Statement


QGEN Free Cash Flow (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   46.6 % -35.76 % 11.93 % 93.14 %


See the full QGEN Cash flow Statement >> Back to QGEN Growth rate Comparisons >>


Free Cash Flow forth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #9
Healthcare Sector #61
Overall #553

Free Cash Flow Y/Y Growth Statistics
High Average Low
46.6 % -9.97 % -100 %
 
Free Cash Flow forth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #9
Healthcare Sector #61
Overall #553
Free Cash Flow Y/Y Growth Statistics
High Average Low
46.6 % -9.97 % -100 %
 

Free Cash Flow by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Qiagen N V 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QGEN's IV. Quarter Q/Q Free Cash Flow Comment


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QGEN's IV. Quarter Q/Q Free Cash Flow Comment


Qiagen N V 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
0		 12 Months Ending
0
Cumulative Free Cash Flow 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #


Cumulative Free Cash Flow growth Comment
In the Dec 31 2024 period, Qiagen N V 's cumulative trailing twelve month Free Cash Flow remained unchanged compare to the same period a year ago.

Qiagen N v achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
In the Dec 31 2024 period, Qiagen N V 's cumulative trailing twelve month Free Cash Flow remained unchanged compare to the same period a year ago.

Qiagen N v achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
QGEN's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for QGEN's Competitors
Free Cash Flow Growth for Qiagen N V 's Suppliers
Free Cash Flow Growth for QGEN's Customers

You may also want to know
QGEN's Annual Growth Rates QGEN's Profitability Ratios QGEN's Asset Turnover Ratio QGEN's Dividend Growth
QGEN's Roe QGEN's Valuation Ratios QGEN's Financial Strength Ratios QGEN's Dividend Payout Ratio
QGEN's Roa QGEN's Inventory Turnover Ratio QGEN's Growth Rates QGEN's Dividend Comparisons



Companies with similar Free Cash Flow jump for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2024
Surgery Partners Inc 77.96%$ 77.955 millions
Alkermes Plc 77.55%$ 77.548 millions
Halozyme Therapeutics Inc 74.36%$ 74.363 millions
Bgm Group Ltd74.32%$ 74.318 millions
Infusystem Holdings Inc70.27%$ 70.266 millions
Fulgent Genetics Inc 67.53%$ 67.535 millions
Semler Scientific inc 67.20%$ 67.199 millions
Illumina Inc 62.50%$ 62.500 millions
Veracyte Inc 57.69%$ 57.690 millions
Brookdale Senior Living Inc 54.29%$ 54.291 millions
Bausch Health Companies Inc 54.10%$ 54.103 millions
Psychemedics Corporation53.93%$ 53.927 millions
Zynex inc 53.83%$ 53.830 millions
National Vision Holdings Inc 53.24%$ 53.241 millions
Bio rad Laboratories Inc 53.19%$ 53.185 millions
Boston Scientific Corporation52.14%$ 52.142 millions
Chemed Corporation51.91%$ 51.905 millions
Perrigo Company Plc49.78%$ 49.784 millions
Abbvie Inc 48.29%$ 48.285 millions
Bausch and Lomb Corp46.67%$ 46.667 millions
Qiagen N v 46.60%$ 46.598 millions
Livanova Plc45.87%$ 45.867 millions
Warby Parker Inc 45.72%$ 45.715 millions
Universal Health Services Inc 45.53%$ 45.533 millions
Teleflex Incorporated45.44%$ 45.444 millions
Atricure Inc 44.81%$ 44.814 millions
Lemaitre Vascular Inc 41.28%$ 41.280 millions
Penumbra Inc40.94%$ 40.945 millions
Lantheus Holdings Inc 40.47%$ 40.470 millions
Encompass Health Corporation38.71%$ 38.706 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com